Columbia: Opening a New Front Against Pancreatic Cancer
April 08, 2024
April 08, 2024
NEW YORK, April 8 (TNSres) -- Columbia University issued the following news:
A new type of investigational therapeutic in development for pancreatic cancer has shown unprecedented tumor-fighting abilities in preclinical models of the disease, suggesting it has the potential to offer novel treatment options for nearly all pancreatic tumors, a comprehensive study has found.
The inhibitors in this new class of oral medications, being developed by Revolution Medicines Inc., . . .
A new type of investigational therapeutic in development for pancreatic cancer has shown unprecedented tumor-fighting abilities in preclinical models of the disease, suggesting it has the potential to offer novel treatment options for nearly all pancreatic tumors, a comprehensive study has found.
The inhibitors in this new class of oral medications, being developed by Revolution Medicines Inc., . . .